The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Liganded Androgen Receptor Interaction with β-Catenin
Open accessAbstract
A yeast two-hybrid assay was employed to identify androgen receptor (AR) protein partners in gonadotropin-releasing hormone neuronal cells. By using an AR deletion construct (AR-(Delta371-485)) as a bait, beta-catenin was identified as an AR-interacting protein from a gonadotropin-releasing hormone neuronal cell library. Immunolocalization of co-transfected AR and FLAG-beta-catenin demonstrated that FLAG-beta-catenin was predominantly cytoplasmic in the absence of androgen. In the presence of 5alpha-dihydrotestosterone, FLAG-beta-catenin completely co-localized to the nucleus with AR. This effect was specific to AR because liganded progesterone, glucocorticoid, or estrogen alpha receptors did not translocate FLAG-beta-catenin to the nucleus. Agonist-bound AR was required because the AR antagonists casodex and hydroxyflutamide failed to translocate beta-catenin. Time course experiments demonstrated that co-translocation occurred with similar kinetics. Nuclear co-localization was independent of the glycogen synthase kinase-3beta, p42/44 ERK mitogen-activated protein kinase, and phosphatidylinositol 3-kinase pathways because inhibitors of these pathways had no effect. Transcription assays demonstrated that liganded AR repressed beta-catenin/T cell factor-responsive reporter gene activity. Conversely, co-expression of beta-catenin/T cell factor repressed AR stimulation of AR-responsive reporter gene activity. Our data suggest that liganded AR shuttles beta-catenin to the nucleus and that nuclear interaction of AR with beta-catenin may modulate transcriptional activity in androgen target tissues.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, ligand-bound AR decreases the transcriptional activity of TCF4 in prostate cancer, colon cancer [21], and neurons [16].”
From The FKBP52 Cochaperone Acts in Synergy with β-Catenin to Potentiate Androgen Receptor Signaling (2015) · cites this paper as [16]
Citations
Cites
Identification of c- MYC as a Target of the APC Pathway
He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · Science · doi:10.1126/science.281.5382.1509 · Cited by 4,566
Functional interaction of β-catenin with the transcription factor LEF-1
Behrens, J., von Kries, J. P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R., & Birchmeier, W. (1996) · Nature · doi:10.1038/382638a0 · Cited by 2,912
Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon Carcinoma
Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., & Clevers, H. (1997) · Science · doi:10.1126/science.275.5307.1784 · Cited by 2,905
β‐catenin is a target for the ubiquitin–proteasome pathway
Aberle, H., Bauer, A., Stappert, J., Kispert, A., & Kemler, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3797 · Cited by 2,586
Transport Between the Cell Nucleus and the Cytoplasm
Görlich, D., & Kutay, U. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.607 · Cited by 2,006
XTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos
Molenaar, M., van de Wetering, M., Oosterwegel, M., Peterson-Maduro, J., Godsave, S., Korinek, V., Roose, J., Destrée, O., & Clevers, H. (1996) · Cell · doi:10.1016/s0092-8674(00)80112-9 · Cited by 1,824
Ozawa, M., Baribault, H., & Kemler, R. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03563.x · Cited by 1,396
Yost, C., Torres, M., Miller, J., Huang, E., Kimelman, D., & Moon, R. T. (1996) · Genes & Development · doi:10.1101/gad.10.12.1443 · Cited by 1,167
Nongenotropic, Sex-Nonspecific Signaling through the Estrogen or Androgen Receptors
Kousteni, S., Bellido, T., Plotkin, L. I., O’Brien, C. A., Bodenner, D., Li, H., Han, K., Gregorio, G. B. D., Katzenellenbogen, J. A., Katzenellenbogen, B. S., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00268-9 · Cited by 1,163
Immortalization of hypothalamic GnRH by genetically targeted tumorigenesis
Mellon, P. L., Windle, J. J., Goldsmith, P. C., Padula, C. A., Roberts, J. L., & Weiner, R. I. (1990) · Neuron · doi:10.1016/0896-6273(90)90028-e · Cited by 960
Flagged first, then by citations
Research works printed but not linked: 14
- Kousteni, 2001, Cell., 104, 719
- Roche, 1992, Mol. Endocrinol., 6, 2229
- Adler, 1993, Mol. Cell. Biol., 13, 6326
- Scarlett, 1995, Mol. Endocrinol., 9, 413
- Jorgensen, 2001, Mol. Endocrinol., 15, 1496
- Jorgensen, 2001, Mol. Endocrinol., 15, 1505
- Curtin, 2001, Mol. Endocrinol., 15, 1906
- Issack, 1998, Cell Growth Differ., 9, 837
- Fukuchi, 1998, Cancer Res., 58, 3526
- Garcia-Rostan, 1999, Cancer Res., 59, 1811
- Mirabelli-Primdahl, 1999, Cancer Res., 59, 3346
- Palacios, 1998, Cancer Res., 58, 1344
- Voeller, 1998, Cancer Res., 58, 2520
- Truica, 2000, Cancer Res., 60, 4709
Cited by
Sorted by citations
The many faces and functions of β‐catenin
Valenta, T., Hausmann, G., & Basler, K. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.150 · Cited by 1,598
TCF/LEFs and Wnt Signaling in the NucleusPreprint
Cadigan, K. M., & Waterman, M. L. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a007906 · Cited by 780
Heemers, H. V., & Tindall, D. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0019 · Cited by 753
Sawakami, K., Robling, A. G., Ai, M., Pitner, N. D., Liu, D., Warden, S. J., Li, J., Maye, P. F., Rowe, D. W., Duncan, R. L., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601000200 · Cited by 399
Interaction of Nuclear Receptors with the Wnt/β-Catenin/Tcf Signaling Axis: Wnt You Like to Know?
Mulholland, D. J., Dedhar, S., Coetzee, G. A., & Nelson, C. C. (2005) · Endocrine Reviews · doi:10.1210/er.2003-0034 · Cited by 377
Singh, R., Artaza, J. N., Taylor, W. E., Braga, M., Yuan, X., Gonzalez-Cadavid, N. F., & Bhasin, S. (2006) · Endocrinology · doi:10.1210/en.2004-1649 · Cited by 369
Wnt/β-catenin signalling in prostate cancer
Kypta, R. M., & Waxman, J. (2012) · Nature Reviews Urology · doi:10.1038/nrurol.2012.116 · Cited by 284
Armstrong, V. J., Muzylak, M., Sunters, A., Zaman, G., Saxon, L., Price, J. S., & Lanyon, L. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703224200 · Cited by 276
PTEN and GSK3β: key regulators of progression to androgen-independent prostate cancer
Mulholland, D. J., Dedhar, S., Wu, H., & Nelson, C. C. (2006) · Oncogene · doi:10.1038/sj.onc.1209020 · Cited by 218
Wnt/β-Catenin and Estrogen Signaling Converge in Vivo
Kouzmenko, A., Takeyama, K., Ito, S., Furutani, T., Sawatsubashi, S., Maki, A., Suzuki, E., Kawasaki, Y., Akiyama, T., Tabata, T., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400331200 · Cited by 214
Cardona‐Gómez, G. P., Pérez, M., Ávila, J., García‐Segura, L. M., & Wandosell, F. G. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.10.008 · Cited by 197
Jordan, B. K., Shen, J. H.-C., Olaso, R., Ingraham, H. A., & Vilain, E. J. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834480100 · Cited by 192
Tabori, N. E., Stewart, L. S., Znamensky, V., Romeo, R. D., Alves, S. E., McEwen, B. S., & Milner, T. A. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.08.048 · Cited by 184
Liu, J., & Farmer, S. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407050200 · Cited by 187
Niemann, C., Undén, A. B., Lyle, S. R., Zouboulis, C. C., Toftgård, R., & Watt, F. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834202100 · Cited by 185
Roles and regulation of Wnt signaling and β-catenin in prostate cancer
Verras, M., & Sun, Z. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.06.004 · Cited by 180
Wnt signaling: multiple functions in neural development
Ille, F., & Sommer, L. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-4552-2 · Cited by 180
Mizokami, A., Koh, E., Fujita, H., Maeda, Y., Egawa, M., Koshida, K., Honma, S., Keller, E. T., & Namiki, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0130 · Cited by 175
Song, L.-N., Herrell, R., Byers, S., Shah, S., Wilson, E. M., & Gelmann, E. P. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.5.1674-1687.2003 · Cited by 169
The Wnt/β-catenin signaling pathway targets PPARγ activity in colon cancer cells
Jansson, E. Å., Are, A., Greicius, G., Kuo, I.-C., Kelly, D., Arulampalam, V., & Pettersson, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405928102 · Cited by 156
Ligand-dependent inhibition of β-catenin/TCF signaling by androgen receptor
Chesire, D. R., & Isaacs, W. B. (2002) · Oncogene · doi:10.1038/sj.onc.1206049 · Cited by 151
Crosstalk between the Androgen Receptor and β-Catenin in Castrate-Resistant Prostate Cancer
Wang, G., Wang, J., & Sadar, M. D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1718 · Cited by 147
Wnt signalling and prostate cancer
Yardy, G., & Brewster, S. (2005) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500794 · Cited by 156
Singh, R., Bhasin, S., Braga, M., Artaza, J. N., Pervin, S., Taylor, W. E., Krishnan, V., Sinha, S. K., Rajavashisth, T. B., & Jasuja, R. (2008) · Endocrinology · doi:10.1210/en.2008-0858 · Cited by 131
Identification of the LIM Protein FHL2 as a Coactivator of β-Catenin
Yu, W., Renard, C.-A., Labalette, C., Wu, Y., Lévy, L., Neuveut, C., Prieur, X., Flajolet, M., Prigent, S., & Buendia, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207216200 · Cited by 132
Mazor, M., Kawano, Y., Zhu, H., Waxman, J., & Kypta, R. M. (2004) · Oncogene · doi:10.1038/sj.onc.1208068 · Cited by 128
Gebhardt, R., Baldysiak-Figiel, A., Krügel, V., Ueberham, E., & Gaunitz, F. (2007) · Progress in Histochemistry and Cytochemistry · doi:10.1016/j.proghi.2006.12.001 · Cited by 131
Schweizer, L., Rizzo, C. A., Spires, T. E., Platero, J. S., Wu, Q., Lin, T.-A., Gottardis, M. M., & Attar, R. M. (2008) · BMC Cell Biology · doi:10.1186/1471-2121-9-4 · Cited by 127
Androgen receptor function is modulated by the tissue-specific AR45 variant
Ahrens‐Fath, I., Politz, O., Geserick, C., & Haendler, B. (2004) · FEBS Journal · doi:10.1111/j.1432-1033.2004.04395.x · Cited by 119
Modulation of Wnt/ -catenin signaling pathway by bioactive food components
Tarapore, R. S., Siddiqui, I. A., & Mukhtar, H. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr305 · Cited by 118
Revisiting the role of Wnt/β-catenin signaling in prostate cancer
Schneider, J. A., & Logan, S. K. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.02.008 · Cited by 115
Beta-catenin signaling in prostate cancer: an early perspective.
Chesire, D. R., & Isaacs, W. B. (2003) · Endocrine Related Cancer · doi:10.1677/erc.0.0100537 · Cited by 116
Analysis of Wnt Gene Expression in Prostate Cancer
Zhu, H., Mazor, M., Kawano, Y., Walker, M. M., Leung, H. Y., Armstrong, K., Waxman, J., & Kypta, R. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2704 · Cited by 115
Mulholland, D. J., Read, J. T., Rennie, P. S., Cox, M., & Nelson, C. C. (2003) · Oncogene · doi:10.1038/sj.onc.1206802 · Cited by 106
Androgen Receptor Coregulators in Prostate Cancer
Rahman, M. M., Miyamoto, H., & Chang, C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0746-3 · Cited by 103
Gebhardt, R., & Hovhannisyan, A. (2009) · Developmental Dynamics · doi:10.1002/dvdy.22041 · Cited by 104
Genetic alterations in juvenile nasopharyngeal angiofibromas
Coutinho‐Camillo, C. M., Brentani, M. M., & Nagai, M. A. (2008) · Head & Neck · doi:10.1002/hed.20775 · Cited by 102
Li, Y., Wang, L., Zhang, M., Melamed, J., Liu, X., Reiter, R. E., Wei, J., Peng, Y., Zou, X., Pellicer, À., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3380 · Cited by 101
Francis, J. C., Thomsen, M. K., Taketo, M. M., & Swain, A. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003180 · Cited by 99
Terry, S., Yang, X., Chen, M., Vacherot, F., & Buttyan, R. E. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20983 · Cited by 99
A Mechanistic Model of Platelet-Rich Plasma Treatment for Androgenetic Alopecia
Gupta, A., & Carviel, J. (2016) · Dermatologic Surgery · doi:10.1097/dss.0000000000000901 · Cited by 98
Gummow, B. M., Winnay, J. N., & Hammer, G. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212677200 · Cited by 96
Kitagawa, T., Matsuda, K., Inui, S., Takenaka, H., Katoh, N., Itami, S., Kishimoto, S., & Kawata, M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1053 · Cited by 95
A Direct β-Catenin-independent Interaction between Androgen Receptor and T Cell Factor 4
Amir, A. L., Barua, M., McKnight, N. C., Cheng, S., Yuan, X., & Balk, S. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301208200 · Cited by 89
Molecular biology of prostate-cancer pathogenesis
Shand, R. L., & Gelmann, E. P. (2006) · Current Opinion in Urology · doi:10.1097/01.mou.0000193384.39351.64 · Cited by 84
Liao, X., Thrasher, J. B., Holzbeierlein, J. M., Stanley, S. D., & Li, B. (2004) · Endocrinology · doi:10.1210/en.2003-1519 · Cited by 86
Khurana, N., & Sikka, S. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092066 · Cited by 81
Masiello, D., Chen, S., Xu, Y., Verhoeven, M. C., Choi, E., Hollenberg, A. N., & Balk, S. P. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0436 · Cited by 75
Beildeck, M. E., Gelmann, E. P., & Stephen, W. B. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.02.001 · Cited by 75
Gentile, M. A., Nantermet, P. V., Vogel, R. L., Phillips, R., Holder, D., Hodor, P. G., Cheng, C., Dai, H. A., Freedman, L. P., & Ray, W. J. (2009) · Journal of Molecular Endocrinology · doi:10.1677/jme-09-0048 · Cited by 75
Wnt signaling in castration-resistant prostate cancer: implications for therapy.
Yokoyama, N. N., Shao, S., Hoang, B. H., Mercola, D., & Zi, X. (2014) · PubMed Central · Cited by 73
Fanelli, M. A., Guevara, M. M. M., Diblasi, Á. M., Gago, F. E., Tello, O. M., Cuello-Carrión, F. D., Callegari, E. A., Bausero, M. A., & Ciocca, D. R. (2008) · Cell Stress and Chaperones · doi:10.1007/s12192-007-0007-z · Cited by 72
Regulation of masculinization: androgen signalling for external genitalia development
Matsushita, S., Suzuki, K., Murashima, A., Kajioka, D., Acebedo, A. R., Miyagawa, S., Haraguchi, R., Ogino, Y., & Yamada, G. (2018) · Nature Reviews Urology · doi:10.1038/s41585-018-0008-y · Cited by 72
Chen, S., Wulf, G. M., Zhou, X. Z., Rubin, M. A., Lu, K. P., & Balk, S. P. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.3.929-939.2006 · Cited by 72
Wright, M. E., Eng, J. K., Sherman, J., Hockenbery, D. M., Nelson, P. S., Galitski, T., & Aebersold, R. H. (2003) · Genome biology · doi:10.1186/gb-2003-5-1-r4 · Cited by 72
Chesire, D. R., Dunn, T. A., Ewing, C. M., Luo, J., & Isaacs, W. B. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3309 · Cited by 73
Synergistic Effects of Coactivators GRIP1 and β-Catenin on Gene Activation
Li, H., Kim, J. H., Koh, S. S., & Stallcup, M. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311374200 · Cited by 70
Jeong, B., Hong, C. Y., Chattopadhyay, S., Park, J., Gong, E., Kim, H., Chun, S., & Lee, K. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0065 · Cited by 67
Maximal Activity of the Luteinizing Hormoneβ-Subunit Gene Requires β-Catenin
Salisbury, T. B., Binder, A. K., Grammer, J. C., & Nilson, J. H. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0383 · Cited by 67
Androgen activates β-catenin signaling in bladder cancer cells
Li, Y., Zheng, Y., Izumi, K., Ishiguro, H., Ye, B., Li, F., & Miyamoto, H. (2013) · Endocrine Related Cancer · doi:10.1530/erc-12-0328 · Cited by 67
Rusmini, P., Sau, D., Crippa, V., Palazzolo, I., Simonini, F., Onesto, E., Martini, L., & Poletti, A. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.015 · Cited by 70
The Androgen Receptor Antagonizes Wnt/β-Catenin Signaling in Epidermal Stem Cells
Kretzschmar, K., Cottle, D. L., Schweiger, P. J., & Watt, F. M. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.242 · Cited by 66
A Mouse Model of Androgenetic Alopecia
Crabtree, J. S., Kilbourne, E. J., Peano, B. J., Chippari, S. M., Kenney, T. F., McNally, C., Wang, W., Harris, H. A., Winneker, R. C., Nagpal, S., et al. (2010) · Endocrinology · doi:10.1210/en.2009-1474 · Cited by 66
Endocrine Disruptors and Prostate Cancer
Corti, M., Lorenzetti, S., Ubaldi, A., Zilli, R., & Marcoccia, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031216 · Cited by 66
Treatment of Androgenetic Alopecia Using PRP to Target Dysregulated Mechanisms and Pathways
Abdin, R., Zhang, Y., & Jimenez, J. J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.843127 · Cited by 75
Liu, X., Allen, J. D., Arnold, J. T., & Blackman, M. R. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn011 · Cited by 65
Beildeck, M. E., Islam, M. T., Shah, S., Welsh, J., & Byers, S. W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007872 · Cited by 64
Hossain, A., & Saunders, G. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300804200 · Cited by 64
Lee, G. T., Kang, D. I., Ha, Y.-S., Jung, Y. S., Chung, J. M., Min, K. S., Kim, T. H., Moon, K. H., Chung, J. M., Lee, D. H., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.23 · Cited by 62
The Glucocorticoid Receptor Represses Cyclin D1 by Targeting the Tcf-β-Catenin Complex
Takayama, S., Rogatsky, I., Schwarcz, L. E., & Darimont, B. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602290200 · Cited by 62
Androgen regulation of the androgen receptor coregulators
Urbanucci, A., Waltering, K. K., Suikki, H. E., Helenius, M. A., & Visakorpi, T. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-219 · Cited by 62
Verras, M., & Sun, Z. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0208 · Cited by 64
Lower levels of nuclear β‐catenin predict for a poorer prognosis in localized prostate cancer
Horvath, L. G., Henshall, S. M., Lee, C. S., Kench, J. G., Golovsky, D., Brenner, P. C., O’Neill, G., Kooner, R., Stricker, P. D., Grygiel, J. J., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20599 · Cited by 58
Basic Science Review: Nitric Oxide—Releasing Prosthetic Materials
Varu, V. N., Tsihlis, N. D., & Kibbe, M. R. (2008) · Vascular and Endovascular Surgery · doi:10.1177/1538574408322752 · Cited by 59
Factors Affecting the Nuclear Localization of β‐Catenin in Normal and Malignant Tissue
Morgan, R. G., Ridsdale, J., Tonks, A., & Darley, R. L. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24803 · Cited by 56
Identification of Putative Androgen Receptor Interaction Protein Modules
Jasavala, R. J., Martinez, H. D., Thumar, J. R., Andaya, A., Gingras, A., Eng, J. K., Aebersold, R. H., Han, D. K. M., & Wright, M. E. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m600169-mcp200 · Cited by 56
A Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland
Pakula, H., Xiang, D., & Li, Z. (2017) · Cancers · doi:10.3390/cancers9020014 · Cited by 55
Divergent Androgen Receptor and Beta-Catenin Signaling in Prostate Cancer Cells
Lee, E., Ha, S., & Logan, S. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141589 · Cited by 52
Interaction of β-Catenin and TIF2/GRIP1 in Transcriptional Activation by the Androgen Receptor
Song, L., & Gelmann, E. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503850200 · Cited by 51
Shahi, P., Seethammagari, M. R., Valdez, J. M., Xin, L., & Spencer, D. M. (2011) · Stem Cells · doi:10.1002/stem.606 · Cited by 50
Regucalcin, a calcium-binding protein with a role in male reproduction?
Laurentino, S., Correia, S., Cavaco, J. E. B., Oliveira, P. F., Sousa, M., Barros, A., & Socorro, S. (2011) · Molecular Human Reproduction · doi:10.1093/molehr/gar075 · Cited by 45
Androgens, ApoE, and Alzheimer's Disease
Raber, J. (2004) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2004.11.re2 · Cited by 48
Pan, Y., Zhang, J., Gazi, M. H., & Young, C. Y. F. (2003) · PubMed · Cited by 44
Natsume, H., Sasaki, S., Kitagawa, M., Kashiwabara, Y., Matsushita, A., Nakano, K., Nishiyama, K., Nagayama, K., Misawa, H., Masuda, H., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.08.019 · Cited by 43
Olkku, A., & Mahonen, A. (2008) · Bone · doi:10.1016/j.bone.2008.11.013 · Cited by 42
Liu, X., Wu, Y., Yao, S., Levine, A. C., Kirschenbaum, A. M., Collier, L., Bauman, W. A., & Cardozo, C. P. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.478487 · Cited by 40
Karvonen, U., Jänne, O. A., & Palvimo, J. J. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.06.018 · Cited by 41
Liu, X., Kirschenbaum, A. M., Shen, Y., Liu, G., Aaronson, S. A., & Levine, A. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0478 · Cited by 40
Otzel, D. M., Lee, J., Ye, F., Borst, S. E., & Yarrow, J. F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061701 · Cited by 40
Mechanism of the Tissue-Specific Action of the Selective Androgen Receptor Modulator S-101479
Furuya, K., Yamamoto, N., Ohyabu, Y., Morikyu, T., Ishige, H., Albers, M., & Endo, Y. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00885 · Cited by 38
Above genetics: Lessons from cerebral development in autism
Williams, E., & Casanova, M. F. (2011) · Translational Neuroscience · doi:10.2478/s13380-011-0016-3 · Cited by 38
Kong, Y., Poon, R. W. M., Nadesan, P., Muccio, T. D., Fodde, R., Khokha, R., & Alman, B. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3112 · Cited by 36
New aspects of pathogenesis of juvenile angiofibroma
Schick, B., & Urbschat, S. (2004) · Hospital Medicine · doi:10.12968/hosp.2004.65.5.13701 · Cited by 33
Fonte, C., Grenier, J., Trousson, A., Chauchereau, A., Lahuna, O., Baulieu, É.-É., Schumacher, M., & Massaad, C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506930102 · Cited by 31
Spillane, M., Schwarz, N. A., & Willoughby, D. S. (2015) · Steroids · doi:10.1016/j.steroids.2015.02.019 · Cited by 30
Expression of b-Catenin in Prostatic Adenocarcinomas A Comparison With Colorectal Adenocarcinomas
Bismar, T. A., Humphrey, P. A., Grignon, D. J., & Wang, H. L. (2004) · American Journal of Clinical Pathology · doi:10.1309/4470-49gv-52h7-d258 · Cited by 30
Read, J. T., Rahmani, M., Boroomand, S., Allahverdian, S., McManus, B. M., & Rennie, P. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702099200 · Cited by 28
Liu, X., Choi, R. Y., Jawad, S., & Arnold, J. T. (2010) · The Prostate · doi:10.1002/pros.21293 · Cited by 28
Role of GAC63 in transcriptional activation mediated by -catenin
Chen, Y., Yang, C.-H., Xia, M., Ou, C. Y., & Stallcup, M. R. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm095 · Cited by 28
Paliouras, M., Zaman, N., Lumbroso, R., Kapogeorgakis, L., Beitel, L. K., Wang, E., & Trifiro, M. A. (2011) · Integrative Biology · doi:10.1039/c1ib00038a · Cited by 28
Metadata
- Authors
- Pawlowski, J. E., Ertel, J. R., Allen, M. P., Xu, M., Butler, C., Wilson, E. M., & Wierman, M. E.
- Affiliations
- Veterans Health Administration (US)
- University of Colorado Health (US)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Wierman, Margaret E.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-06
- Volume
- 277
- Issue
- 23
- Pages
- 20702-20710
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2033728702
- Cited by
- 166
- References
- 66
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 2 · 2022: 4 · 2021: 4 · 2020: 1 · 2019: 3 · 2018: 5 · 2017: 3 · 2016: 2 · 2015: 5 · 2014: 6 · 2013: 10 · 2012: 4
- FWCI
- 6.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- androgen receptor, β-catenin, protein-protein interaction, nuclear translocation, dihydrotestosterone, GnRH neurons, transcriptional repression, T-cell factor, bicalutamide, hydroxyflutamide, androgen receptor antagonists, transcriptional regulation
- MeSH terms
- Androgen Antagonists, Animals, Cell Line, Cell Nucleus, Cytoskeletal Proteins, Immunohistochemistry, Ligands, Neurons, Precipitin Tests, Promoter Regions, Genetic, Receptors, Androgen, Receptors, Estrogen, Receptors, Glucocorticoid, Receptors, Progesterone, Transcription, Genetic, Blotting, Western, Trans-Activators, COS Cells, Two-Hybrid System Techniques, Protein Transport, Estrogen Receptor alpha, beta Catenin, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review